PGC-1β KO mice show a specific decrease in Mfn2 expression in skeletal muscle. by Marc Liesa (35879)

Revisiting the sealed heating method–V158411 decreases Chk1 nuclear immunofluorescence in HT29 cells heated in a low well volume. by Andrew J. Massey (239469)

Excision of HIF1α decreases viral reactivation from latency in infected splenocytes in vivo. by Darlah M. López-Rodríguez (8098544)

miR-214 decreased the number of viable cells and induced apoptosis in HSA cell lines. by Kazuki Heishima (791938)

“…<p>(A) Cell viability was assessed by performing the MTT assay. miR-214-transfection decreased the number of viable cells in HSA cell lines and that of control EC. …”

TachypleginA treatment causes a decrease in the motor activity of the TgMyoA motor complex. by Aoife T. Heaslip (207534)

D120, E124 and E127 in the VPS52 CC interact with RNF41 resulting in decreased RNF41 oligomerization. by Delphine Masschaele (4040204)

Reversal of cortisone-mediated decrease in dermal total collagen content upon treatment with selected compounds. by Stéphanie M. Boudon (3714205)

Introduction of the D409V point mutation to the <i>GBA1</i> gene does not affect <i>GBA1</i> mRNA transcription or GCase protein translation. by Nicole K. Polinski (10947787)

n-3 PUFA depletion leads to decreased hepatic fatty acid oxidation and increased TG secretion and synthesis. by Barbara D. Pachikian (155501)

Currents of BK channel are decreased in CRL4^CRBN deficient glioma cells. by Tianyu Song (4797417)

PF treatment decreases the mRNA expressions of TNFα (A) and IL-1β (B) in the brain. by Ruo-Bing Guo (298949)

Cofilin concentration selectively decreases in spines following nLTD and involves the capthepsin B/L class of proteases. by Barbara Calabrese (553229)

“…(<b>A₁</b>) Representative example of an eGFP-expressing dendrite costained for phosphorylated (<i>p-cof</i>) and total cofilin (<i>cof</i>). …”

EB1 depletion decreases tau secretion. by C. Laura Sayas (6250811)

“…<p>A) Different levels of EB1 downregulation upon transduction of five different specific shRNAs for human EB1 in HEK-293-tau3R cells. …”

Additional behavioral patterns in the 5€, 100€, and 1000€ treatments. by Pablo Brañas-Garza (336425)

POS treatment decreases ROS level and upregulates mitochondrial biogenesis in ARPE-19 cells through PGC-1α. by Murilo F. Roggia (755997)

“…<p><b>(A)</b> POS treatment upregulated mRNA levels of anti-oxidant enzymes including GPx1, GPx4, SOD1 and catalase. Mean ± SEM, n = 6 per group, two-tailed Student’s <i>t</i>-test, ** <i>P</i> < 0.01, *** <i>P</i> < 0.001; ns, not significant. …”

ApoA-1 concentrations are decreased in non-active RA but correlate with the inhibitory serum activity in active RA by Manuela Rossol (60630)

Decrease in <i>Sox2</i> expression results in similar phenotypes as disruptions to FGFR1 signaling. by Lu M. Yang (6919364)

Ameliorative effect of yokukansan on glutamate-induced decrease in GSH levels in PC12 cells. by Hitomi Kanno (584976)

Inhibition of TNF and/or IL-1 pathways decreases release of CXCL8 and CCL5 but not CXCL10 and IFNs induced by influenza infection. by Jieru Wang (179734)

N-termini sequence alignment of representatives of phylogenetic groups of IPTases. by Abdul Khalique (5029442)